Compounds > 10-propargyl-10-deazaaminopterin
Page last updated: 2024-09-04

10-propargyl-10-deazaaminopterin and indazoles

10-propargyl-10-deazaaminopterin has been researched along with indazoles in 1 studies

Compound Research Comparison

Studies
(10-propargyl-10-deazaaminopterin)		Trials
(10-propargyl-10-deazaaminopterin)		Recent Studies (post-2010)
(10-propargyl-10-deazaaminopterin)		Studies
(indazoles)		Trials
(indazoles)		Recent Studies (post-2010) (indazoles)
11921855,6095503,265

Protein Interaction Comparison

ProteinTaxonomy10-propargyl-10-deazaaminopterin (IC50)indazoles (IC50)
Chain A, Cell Division Protein Kinase 2Homo sapiens (human)185
Chain A, CELL DIVISION PROTEIN KINASE 2Homo sapiens (human)185
Chain A, Cell Division Protein Kinase 2Homo sapiens (human)185
Chain A, CELL DIVISION PROTEIN KINASE 2Homo sapiens (human)185
Chain A, CELL DIVISION PROTEIN KINASE 2Homo sapiens (human)185
Chain A, CELL DIVISION PROTEIN KINASE 2Homo sapiens (human)185
Chain A, CELL DIVISION PROTEIN KINASE 2Homo sapiens (human)185
Chain A, CELL DIVISION PROTEIN KINASE 2Homo sapiens (human)185
Chain A, CELL DIVISION PROTEIN KINASE 2Homo sapiens (human)185
Chain A, CELL DIVISION PROTEIN KINASE 2Homo sapiens (human)185
Chain A, CELL DIVISION PROTEIN KINASE 2Homo sapiens (human)185
Chain A, CELL DIVISION PROTEIN KINASE 2Homo sapiens (human)185
Chain A, CELL DIVISION PROTEIN KINASE 2Homo sapiens (human)185
Chain A, Cell Division Protein Kinase 2Homo sapiens (human)185

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies

Other Studies

1 other study(ies) available for 10-propargyl-10-deazaaminopterin and indazoles

ArticleYear
StatBite: FDA oncology drug product approvals in 2009.
    Journal of the National Cancer Institute, 2010, Feb-24, Volume: 102, Issue:4

    Topics: Administration, Oral; Aminopterin; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Cetuximab; Depsipeptides; Drug Approval; Everolimus; Ferrosoferric Oxide; Glutamates; Guanine; Humans; Indazoles; Injections; Panitumumab; Pemetrexed; Pyrimidines; Sirolimus; Sulfonamides; United States; United States Food and Drug Administration

2010